OSI Brushes Off Hostile Bid, Cancer Stocks Surge
OSI Pharmaceuticals soared by over 50% on Monday after receiving an unsolicited buyout bid from Astellas Pharma worth $52 per share.
Read more on Indie Research via Yahoo! Finance
Bio-techs Surge With Profits: Tfn Smart Investing Stock Brea
http://www.taipanfinancialn… — Big pharma has a hit a brick wall. Hundreds of patents are set to expire leaving drug companies with limit revenue streams and no new treatments on the horizon. …